Site Search

Share

X

Search Results

Higher Cig Tax is Good Public Policy

...   “Say the word ‘tax’ and people cringe.   But a higher tax on cigarettes is one tax New Yorkers can feel good about.   A proven public health strategy, it will raise money targeted for health care programs and reduce health care costs by increasing the numbers of smokers who decide to ditch the cancer sticks for good.       Critics ...

American Cancer Society Cancer Action Network Opposes Legislation Threatening Access to Mammograms

... is a statement by Daniel E. Smith, National Vice President of Government Relations for the American Cancer Society, in opposition to the Health Insurance Marketplace Modernization and Affordability Act (S. 1955). The legislation threatens access to lifesaving mammograms and other cancer prevention and treatment services by all allowing Access to Health Care plans to skirt state consumer protections provided they offer a plan that includes the same protections as any one of the plans offered to ...

Federal Court Orders FDA to Issue Final Rule Requiring Graphic Cigarette Warnings by March 15, 2020

WASHINGTON, D.C. – In a major victory for the nation’s health and the fight against tobacco, a federal court on Tuesday ordered the U.S. Food and Drug Administration (FDA) to issue a final rule mandating graphic health warnings on cigarette packs and advertising by March 15, 2020. The order by U.S. District Judge Indira Talwani of the U.S. District Court ... and motivating smokers to quit. Requiring graphic cigarette warnings in the U.S. will protect kids, save lives and reduce tobacco-related health care costs, which total $170 billion a year. The 2016 lawsuit was filed by the American Academy of Pediatrics, the Massachusetts Chapter of the ...

Nation 's Leading Cancer Groups Urging Congress to Oppose Cuts to Cancer Research, Prevention Programs

... colonoscopies. A House-passed proposal to fund the federal government for the remainder of the fiscal year would cut the National Institutes of Health (NIH) budget by 5.2 percent and the Centers for Disease Control and Prevention (CDC) budget by 21 percent. “The proposed cuts would mark a ... CDC. OVAC members are calling on Congress to support funding for: • Cutting-edge research at the NIH, NCI, and National Institute on Minority Health and Health Disparities that holds the promise of producing groundbreaking cancer treatments and ways to expand access to them. • CDC ... targeting skin, prostate, ovarian and blood cancers. • The HRSA Patient Navigator Program, which helps cancer patients navigate the health care system and overcome barriers to health care, and HRSA Title VIII Nursing Programs. • Efforts at the Food and Drug Administration to further ...

One Year Anniversary of Cancer Moonshot Reignition Brings Progress and Opportunity

... Roundtable in October. Using an ‘all-hands-on-deck approach,’ the roundtables convene scientists, the medical community, leading public health agencies, the private sector and community organizations to catalyze change and investment across the cancer continuum. Just weeks ago, ACS ... treatment have free lodging so they can focus on treatment. ACS CAN is joining a new coalition of diverse stakeholders to address barriers to health care faced by rural communities, including technology and infrastructure limitations. Beyond the private commitments announced today, the White ...

North Dakota Cancer Summit Research Reception 2019

... American Cancer Society Cancer Action Network (ACS CAN) North Dakota Cancer Summit is a premier event that brings together community leaders in health care, cancer control, business, education, government and research for meaningful discussions on evidence-based policy to reduce the burden of cancer.  The topic of the fifth annual Cancer Summit is The Future of Cancer Care from Discovery to Delivery: Cancer Research . You will hear from National and local experts in the field of cancer research, including Dr. ...

2020 ACS CAN Texas Cancer Policy Forum Series

... Network (ACS CAN) will host its seventh annual Texas Cancer Policy Forum series this fall, uniting key leaders and decision makers in business, health care, and government to consider the evolving needs of Texans accessing and affording equitable cancer care. Texas institutions are generating exciting new life-saving therapies and making advances in the fight against cancer, with significant ...

Medicare Drug Rule Could Leave Patients Unable to Access Necessary Prescription Medications

... the need to make prescription drugs more affordable. However, the countries included through the Most Favored Nation policy have very different health systems and supply chains than the United States, which could mean some cancer medications are unavailable, and patients are unable to get essential care and treatment.  “The United States is often the first to approve innovative new cancer therapies and it is unclear how or whether such ...

Expand Access to Biomarker Testing in Nevada

... and partners are working together to make sure more Nevadans can benefit from this important testing.   What is Biomarker Testing? In cancer care, biomarkers are often used to help determine the best treatment for a patient . A “ biomarker ” is a sign of a normal biological process, ... that have been excluded, including communities of color, individuals with lower socioeconomic status, rural communities, and those receiving care in non-academic medical centers are less likely to receive biomarker testing. Improving coverage for and access to biomarker testing across insurance types is key to reducing health disparities. Without action to expand coverage and access to biomarker testing, advances in precision medicine could increase existing ...

Expand Access to Biomarker Testing in Washington

... partners are working together to make sure more Washingtonians can benefit from this important testing.   What is Biomarker Testing? In cancer care, biomarkers are often used to help determine the best treatment for a patient . A “ biomarker ” is a sign of a normal biological process, ... that have been excluded, including communities of color, individuals with lower socioeconomic status, rural communities, and those receiving care in non-academic medical centers are less likely to receive biomarker testing. Improving coverage for and access to biomarker testing across insurance types is key to reducing health disparities. Without action to expand coverage and access to biomarker testing, advances in precision medicine could increase existing ...

Type

Priority Issue

State

Policy Issue

Judicial Advocacy